MMR on 12 Month

Clinical trial pipeline · Data from ClinicalTrials.gov

See which MMR on 12 Month trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingPhase 3

NCT06855160

A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rub…

This study aims to assess the immune response and safety of GSK's candidate chickenpox and marketed MMR vaccines when given to children 12 to 15 months of age v…

United States900 participantsStarted 2025-04-17

Treatment: Candidate varicella vaccine, Marketed varicella vaccine

RecruitingNot Applicable

NCT05341050

A Study on the Withdrawal of Second-generation Tyrosine Kinase Inhibitors After Dose Reduction in Patients With CML

patients with Ph+ CML-CP who have been treated with second-generation TKIs (nilotinib, dasatinib) for at least 3 years and maintains MMR for at least 2 years, c…

China260 participantsStarted 2022-04-01

Treatment: TKI

All recent trials (3 shown)

UnknownNot Applicable

NCT04143087

Withdrawal or Reduction TKIs in CML-CP

Compare MMR on 12 month treated with half TKIs(including imatinib, dasatinib, and nilotinib) or TKIs withdrawal.

China100 participantsStarted 2019-10-23

Treatment: withdrawal TKIs or halve TKIs